Tilray Brands, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Tilray Brands, Inc. (TLRY) reported Foreign Currency Transaction Gain (Loss), before Tax of $6.59 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-07-28
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-05-31 was -$2.48M, a 104.60% decline year-over-year.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-02-28 was $12.47M.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-11-30 was -$10.33M.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-08-31 was $6.93M, a 41.69% decline year-over-year.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for fiscal 2026 was $6.59M, a 31.61% decline from fiscal 2025.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $9.64M.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$4.09M.
- Tilray Brands, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$25.54M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $9.99M derived: sum of 2 quarters · filed 2026-07-28 | -$336.00K derived: sum of 3 quarters · filed 2026-07-28 | $6.59M 10-K · filed 2026-07-28 | |||
| 2026-02-28 | $12.47M 10-Q · filed 2026-04-01 | $2.14M derived: sum of 2 quarters · filed 2026-04-01 | $9.07M 10-Q · filed 2026-04-01 | $62.91M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-11-30 | -$10.33M 10-Q · filed 2026-01-08 | -$3.40M 10-Q · filed 2026-01-08 | $50.45M derived: sum of 3 quarters · filed 2026-07-28 | $28.16M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-08-31 | $6.93M 10-Q · filed 2025-10-09 | $60.77M derived: sum of 2 quarters · filed 2026-07-28 | $38.48M derived: sum of 3 quarters · filed 2026-07-28 | $4.69M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-05-31 | $53.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $31.55M derived: sum of 2 quarters · filed 2026-07-28 | -$2.24M derived: sum of 3 quarters · filed 2026-07-28 | $9.64M 10-K · filed 2026-07-28 | |||
| 2025-02-28 | -$22.29M 10-Q · filed 2026-04-01 | -$56.09M derived: sum of 2 quarters · filed 2026-04-01 | -$44.21M 10-Q · filed 2026-04-01 | -$50.23M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-11-30 | -$33.80M 10-Q · filed 2026-01-08 | -$21.92M 10-Q · filed 2026-01-08 | -$27.94M derived: sum of 3 quarters · filed 2026-07-28 | -$31.25M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-08-31 | $11.88M 10-Q · filed 2025-10-09 | $5.85M derived: sum of 2 quarters · filed 2026-07-28 | $2.55M derived: sum of 3 quarters · filed 2026-07-28 | $1.53M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2024-05-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | -$9.33M derived: sum of 2 quarters · filed 2026-07-28 | -$10.35M derived: sum of 3 quarters · filed 2026-07-28 | -$4.09M 10-K · filed 2026-07-28 | |||
| 2024-02-29 | -$3.30M 10-Q · filed 2025-04-08 | -$4.33M derived: sum of 2 quarters · filed 2025-04-08 | $1.94M 10-Q · filed 2025-04-08 | $3.03M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-11-30 | -$1.02M 10-Q · filed 2025-01-10 | $5.24M 10-Q · filed 2025-01-10 | $6.33M derived: sum of 3 quarters · filed 2025-07-29 | $4.37M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-08-31 | $6.27M 10-Q · filed 2024-10-10 | $7.35M derived: sum of 2 quarters · filed 2025-07-29 | $5.40M derived: sum of 3 quarters · filed 2025-07-29 | $6.30M derived: sum of 4 quarters · filed 2025-07-29 | |||
| 2023-05-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$869.00K derived: sum of 2 quarters · filed 2025-07-29 | $38.00K derived: sum of 3 quarters · filed 2025-07-29 | -$25.54M 10-K · filed 2025-07-29 | |||
| 2023-02-28 | -$1.96M 10-Q · filed 2024-04-09 | -$1.05M derived: sum of 2 quarters · filed 2024-04-09 | -$26.62M 10-Q · filed 2024-04-09 | -$36.55M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-11-30 | $907.00K 10-Q · filed 2024-01-09 | -$24.67M 10-Q · filed 2024-01-09 | -$34.60M derived: sum of 3 quarters · filed 2024-10-10 | -$37.15M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-08-31 | -$25.57M 10-Q · filed 2024-10-10 | -$35.50M derived: sum of 2 quarters · filed 2024-10-10 | -$38.05M derived: sum of 3 quarters · filed 2024-10-10 | -$48.23M derived: sum of 4 quarters · filed 2024-10-10 | |||
| 2022-05-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$12.48M derived: sum of 2 quarters · filed 2024-07-30 | -$22.66M derived: sum of 3 quarters · filed 2024-07-30 | -$28.38M 10-K · filed 2024-07-30 | |||
| 2022-02-28 | -$2.55M 10-Q · filed 2023-04-10 | -$12.73M derived: sum of 2 quarters · filed 2023-04-10 | -$18.45M 10-Q · filed 2023-04-10 | -$17.21M derived: sum of 4 quarters · filed 2023-07-26 | |||
| 2021-11-30 | -$10.18M 10-Q · filed 2023-01-09 | -$15.90M 10-Q · filed 2023-01-09 | -$14.66M derived: sum of 3 quarters · filed 2023-07-26 | ||||
| 2021-08-31 | -$5.72M 10-Q · filed 2022-10-07 | -$4.49M derived: sum of 2 quarters · filed 2023-07-26 | |||||
| 2021-05-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | -$22.35M 10-K · filed 2023-07-26 | |||||
| 2021-03-31 | $699.00K 10-Q · filed 2021-05-10 | ||||||
| 2021-02-28 | -$3.88M 10-Q · filed 2022-04-06 | -$23.59M 10-Q · filed 2022-04-06 | |||||
| 2020-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $13.17M 10-K · filed 2021-02-19 | |||||
| 2020-11-30 | -$3.37M 10-Q · filed 2022-01-10 | -$19.70M 10-Q · filed 2022-01-10 | |||||
| 2020-09-30 | -$9.32M 10-Q · filed 2020-11-09 | $5.42M 10-Q · filed 2020-11-09 | |||||
| 2020-08-31 | -$16.33M 10-Q · filed 2021-10-07 | ||||||
| 2020-06-30 | -$13.33M 10-Q · filed 2020-08-10 | $14.74M 10-Q · filed 2020-08-10 | -$36.60M derived: sum of 3 quarters · filed 2021-05-10 | -$34.02M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2020-05-31 | $6.14M 10-K · filed 2022-07-28 | ||||||
| 2020-03-31 | -$28.07M 10-Q · filed 2021-05-10 | -$23.28M derived: sum of 2 quarters · filed 2021-05-10 | -$20.69M derived: sum of 3 quarters · filed 2021-05-10 | -$22.30M derived: sum of 4 quarters · filed 2021-05-10 | |||
| 2019-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $7.38M derived: sum of 2 quarters · filed 2021-02-19 | $5.76M derived: sum of 3 quarters · filed 2021-02-19 | $5.94M 10-K · filed 2021-02-19 | |||
| 2019-09-30 | $2.58M 10-Q · filed 2020-11-09 | -$2.58M 10-Q · filed 2019-11-13 | $974.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.15M 10-Q · filed 2020-11-09 | -$1.15M 10-Q · filed 2019-11-13 | -$5.53M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-06-30 | -$1.61M 10-Q · filed 2020-08-10 | $1.61M 10-Q · filed 2019-08-13 | -$1.43M 10-Q · filed 2020-08-10 | $1.43M 10-Q · filed 2019-08-13 | -$8.11M derived: sum of 3 quarters · filed 2021-02-19 | -$6.52M derived: sum of 4 quarters · filed 2021-02-19 | |
| 2019-05-31 | $692.00K 10-K · filed 2021-07-28 | ||||||
| 2019-03-31 | -$179.00K 10-Q · filed 2020-05-11 | -$6.50M derived: sum of 2 quarters · filed 2021-02-19 | -$4.91M derived: sum of 3 quarters · filed 2021-02-19 | -$6.27M derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2018-12-31 | -$6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$4.73M derived: sum of 2 quarters · filed 2021-02-19 | -$6.09M derived: sum of 3 quarters · filed 2021-02-19 | -$7.23M 10-K · filed 2021-02-19 | |||
| 2018-09-30 | $1.59M 10-Q · filed 2019-11-13 | $1.59M 10-Q · filed 2018-11-14 | $233.00K derived: sum of 2 quarters · filed 2019-11-13 | -$913.00K 10-Q · filed 2019-11-13 | -$967.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | -$1.36M 10-Q · filed 2019-08-13 | -$1.36M 10-Q · filed 2018-08-29 | -$2.50M 10-Q · filed 2019-08-13 | -$2.56M derived: sum of 3 quarters · filed 2020-03-02 | -$1.72M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | -$1.15M 10-Q · filed 2019-05-15 | -$1.20M derived: sum of 2 quarters · filed 2020-03-02 | -$362.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.00K derived: sum of 4 quarters · filed 2020-03-02 | |||
| 2017-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $784.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.15M derived: sum of 3 quarters · filed 2020-03-02 | $1.36M 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $838.00K 10-Q · filed 2018-11-14 | $1.20M derived: sum of 2 quarters · filed 2018-11-14 | $1.42M 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $361.00K 10-Q · filed 2018-08-29 | $580.00K 10-Q · filed 2018-08-29 | |||||
| 2016-12-31 | $186.00K 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |